Analyst firms · Vertical Research · SOLS

Vertical Research SOLS price target and rating history

Solstice Advanced Materials Inc. (SOLS) · Industrials

Vertical Research rates Solstice Advanced Materials Inc. (SOLS) Buy with a $79 price target, as of its latest action on Jul 22, 2026. It has published 3 rating actions on SOLS since January 2026, including 2 upgrades and 1 downgrade. Across 8 firms with a SOLS price target in the last 12 months, the median target is $78.50. Vertical Research's $79 is 1% above that.

Current rating
Buy
Price target
$79
Median target, all firms
$78.50
Actions on SOLS
3

Vertical Research price target on SOLS

$90$74$58
Vertical Research price target on SOLS, each point a stated target, January 2026 to July 2026.

Every Vertical Research rating on SOLS

How other firms rate SOLS

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
BarclaysOverweight$73Oct 13, 2026
Seaport Research PartnersBuy$80Oct 7, 2026
JefferiesBuy$86Sep 3, 2026
Vertical ResearchBuy$79Jul 22, 2026
UBSBuy$78Jul 13, 2026
Truist SecuritiesBuy$48Jul 9, 2026
TD CowenHold$90Jun 8, 2026
RBC Capital MarketsOutperform$75Jan 20, 2026

Questions about Vertical Research and SOLS

What is Vertical Research's price target for SOLS?
Vertical Research's latest stated price target for Solstice Advanced Materials Inc. (SOLS) is $79, from its action on Jul 22, 2026.
What is Vertical Research's rating on SOLS?
Vertical Research rates SOLS Buy, a bullish rating, as of Jul 22, 2026.
When did Vertical Research last change its view on SOLS?
On Jul 22, 2026, Vertical Research upgrades to Buy from Hold, price target $79.
How does Vertical Research's SOLS target compare with other analysts?
Across 8 firms with a SOLS price target in the last 12 months, the median target is $78.50. Vertical Research's $79 is 1% above that.

More SOLS rating histories

All Vertical Research ratingsSOLS news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.